Pitcairn Co. Sells 99 Shares of LHC Group, Inc. (NASDAQ:LHCG)

Pitcairn Co. cut its position in shares of LHC Group, Inc. (NASDAQ:LHCG) by 2.9% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,334 shares of the health services provider’s stock after selling 99 shares during the quarter. Pitcairn Co.’s holdings in LHC Group were worth $523,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in LHCG. First Trust Advisors LP boosted its position in shares of LHC Group by 4.8% during the first quarter. First Trust Advisors LP now owns 34,900 shares of the health services provider’s stock valued at $3,869,000 after purchasing an additional 1,591 shares in the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp raised its stake in LHC Group by 3.2% during the second quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 535,565 shares of the health services provider’s stock valued at $107,252,000 after buying an additional 16,630 shares during the last quarter. Van ECK Associates Corp purchased a new position in LHC Group during the second quarter valued at $74,000. Mercer Global Advisors Inc. ADV raised its stake in LHC Group by 14.9% during the second quarter. Mercer Global Advisors Inc. ADV now owns 4,401 shares of the health services provider’s stock valued at $881,000 after buying an additional 570 shares during the last quarter. Finally, Deutsche Bank AG raised its stake in LHC Group by 65.9% during the second quarter. Deutsche Bank AG now owns 52,032 shares of the health services provider’s stock valued at $10,420,000 after buying an additional 20,670 shares during the last quarter. Institutional investors own 93.35% of the company’s stock.

NASDAQ LHCG opened at $131.42 on Friday. The firm has a market cap of $4.16 billion, a price-to-earnings ratio of 31.67, a price-to-earnings-growth ratio of 1.70 and a beta of 0.37. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.21. The business has a 50-day moving average price of $132.03 and a 200-day moving average price of $163.27. LHC Group, Inc. has a twelve month low of $108.42 and a twelve month high of $223.80.

LHC Group (NASDAQ:LHCG) last released its quarterly earnings data on Wednesday, November 3rd. The health services provider reported $1.45 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.45. The firm had revenue of $565.45 million during the quarter, compared to analyst estimates of $565.30 million. LHC Group had a return on equity of 11.07% and a net margin of 6.01%. During the same quarter in the prior year, the company posted $1.63 earnings per share. Research analysts expect that LHC Group, Inc. will post 5.78 EPS for the current fiscal year.

A number of research analysts have issued reports on LHCG shares. Zacks Investment Research upgraded LHC Group from a “strong sell” rating to a “hold” rating and set a $136.00 price objective for the company in a research note on Monday, December 20th. UBS Group initiated coverage on LHC Group in a research note on Thursday, September 23rd. They issued a “neutral” rating and a $170.00 price target for the company. Cowen cut LHC Group from an “outperform” rating to a “market perform” rating and decreased their price target for the stock from $209.00 to $150.00 in a research note on Tuesday, October 26th. Barclays decreased their price target on LHC Group from $207.00 to $171.00 and set an “equal weight” rating for the company in a research note on Friday, November 5th. Finally, Truist decreased their price target on LHC Group from $240.00 to $185.00 and set a “buy” rating for the company in a research note on Wednesday, October 13th. Five investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, LHC Group has an average rating of “Buy” and an average price target of $173.82.

In other news, EVP Nicholas Gachassin III sold 800 shares of the company’s stock in a transaction dated Thursday, December 16th. The stock was sold at an average price of $125.25, for a total value of $100,200.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 4.80% of the company’s stock.

LHC Group Company Profile

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Featured Article: Analyst Ratings Trading

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.